Tag:

Depression

Kim Kardashian Sued: Star Mistakenly ID'd Hudson Valley Man's Photo As Death Row Inmate Kim Kardashian Sued: Star Mistakenly ID'd Hudson Valley Man's Photo As Death Row Inmate
Kim Kardashian Sued: Star Mistakenly ID'd Hudson Valley Man's Photo As Death Row Inmate Reality TV star and business mogul Kim Kardashian is facing a lawsuit over allegations that she falsely identified a New York man as a convicted murderer on Instagram, causing him serious emotional distress. Westchester County resident Ivan Cantu filed the lawsuit against the celebrity on Thursday, Feb. 20, alleging that Kardashian wrongfully posted his photo on Instagram to her 350 million followers, claiming he was a convicted murderer on death row, according to New York-based Sobo & Sobo Personal Injury Attorneys.  The case includes six counts, including libel, slander…
NY Ranks Among Best States For Women’s Healthcare In New Study: Here’s Why NY Ranks Among Best States For Women’s Healthcare In New Study: Here’s Why
NY Ranks Among Best States For Women’s Healthcare In New Study: Here’s Why Several northeast states are among the best in the nation for women’s health, leading in healthcare access, affordability, and safety, a new study said. Massachusetts was ranked as the best state for women’s health in 2025, according to a study released by SmileHub on Tuesday, Feb. 4. The Bay State finished narrowly ahead of second-place Hawaii, while Connecticut, New York, and New Jersey rounded out the top five. The report evaluated all 50 states using 18 key metrics, including maternal mortality rates, hospital quality, and the cost of medical care. The findings highlight major disp…
Nasal Spray Treating Major Depression Receives FDA Approval For Standalone Use Nasal Spray Treating Major Depression Receives FDA Approval For Standalone Use
Nasal Spray Treating Major Depression Receives FDA Approval For Standalone Use The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of depression, officials said. The FDA granted approval to Spravato (esketamine) as the first monotherapy for adults with treatment-resistant depression, J&J said in a news release on Tuesday, Jan. 21. The decision came after a priority review of clinical data showing significant improvements in depression symptoms as early as 24 hours and sustained progress through four weeks. According to J&J, treatment-resistant depression affects about one-t…